Actively Recruiting
Evaluating Cardioneuroablation Versus Sham Procedure for Treating Symptomatic Bradyarrhythmias in Adults Aged 18-65 with Sinus Node or Atrioventricular Node Dysfunction
Led by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · Updated on 2024-03-05
106
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and effectiveness of cardioneuroablation as a treatment for symptomatic bradycardia without the need for permanent pacemaker implantation. This multicenter, prospective, randomized, and blinded controlled trial compares cardioneuroablation with a sham procedure in patients suffering from severe bradycardia due to sinus node dysfunction andor atrioventricular node dysfunction. The study aims to assess whether cardioneuroablation can serve as an alternative to pacemaker implantation for patients with certain heart rhythm disorders and related conditions such as vasovagal syncope.
CONDITIONS
Brief Title
Cardioneuroablation for Bradyarrhythmia
Research Team
A
Aleksandr Vakhrushev, PhD
E
Evgeny Mikhaylov, PhD, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
